Blood cancers

Role for cytarabine in MCL but questions remain: expert

Results from a landmark clinical trial are likely to cement in place the role of cytarabine in front-line therapy for younger patients with mantle cell lymphoma, but a lingering question remains, an expert says. The phase 3 study from the European Mantle Cell Lymphoma Network founded in 1996 involved 497 patients aged under 65 years ...

Already a member?

Login to keep reading.

© 2021 the limbic